SubjectWell, a patient recruitment platform for clinical trials, announced it raised $35 million in a Series B funding round led by Asset Management Ventures.
Other participants in the round include Bertelsmann and existing investors Healthy Ventures, Windham Venture Partners and Geekdom Fund.
According to Crunchbase, the Texas-based company has raised $46.8 million over seven funding rounds....
Decentralized clinical trial company Curebase is partnering with Meru Health on a three-year clinical trial to study the effectiveness of Meru's 12-week treatment program aimed at reducing depression among primary care patients.
Meru Health's smartphone-based, therapist-guided treatment program targets depression, burnout and anxiety, while Curebase provides a decentralized clinical trial...
Decentralized clinical trial company THREAD announced Tuesday it has acquired CureClick, a platform for recruiting trial participants.
The latest deal is THREAD's third acquisition announcement in less than six months. In January, the company said it had scooped up inVibe, which aims to use patient voice data for research. THREAD also acquired Modus Outcomes, a research design consultancy, in...
Thread, a North Carolina startup focused on decentralized clinical research tech, announced its purchase of voice-powered research company inVibe for an undisclosed sum.
inVibe uses machine learning algorithms and human analysis to capture data and gain insights. The technology can be used to collect real-world patient voice data during a clinical trial.
“inVibe adds capabilities to the Thread...
Exo, a Silicon Valley company known for its in-development handheld ultrasound device, announced $40 million in new funding yesterday. GlaxoSmithKline's Investor Action Potential Venture Capital fund was among the Series B+ round's unnamed investors.
Exo said in its announcement that it will be using the funds to wrap up product development for that device, and to bring its data and workflow apps...
Yesterday private equity firms Water Street Health Partners and JLL Partners announced that they had acquired virtual clinical research company Thread for an undisclosed amount. The new owners say they plan on investing in Thread in order to further expand its customer base and offer the platform on a global scale.
Thread’s platform is aimed at improving clinical trial research data and making...
_7.JPG?itok=jgI8PYal)
